Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria

Saved in:
Bibliographic Details
Published in:Blood Vol. 136; pp. 35 - 37
Main Authors: Castro, Carlos de, Hillmen, Peter, Szer, Jeff, Weitz, Ilene, Röth, Alexander, Hoechsmann, Britta, Panse, Jens, Usuki, Kensuke, Griffin, Morag, Kiladjian, Jean-Jacques, Nishimori, Hisakazu, Tan, Lisa, Hamdani, Mohamed, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Risitano, Antonio, Latour, Regis Peffault de
Format: Journal Article
Language:Japanese
Published: American Society of Hematology 01.09.2020
Subjects:
Diseases of the blood and blood-forming organs
Medizin
RC633-647.5
ISSN:0006-4971, 1528-0020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0006-4971
1528-0020
DOI:10.1016/s2152-2650(20)30783-7